ES3025983T3 - Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss - Google Patents
Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss Download PDFInfo
- Publication number
- ES3025983T3 ES3025983T3 ES21750999T ES21750999T ES3025983T3 ES 3025983 T3 ES3025983 T3 ES 3025983T3 ES 21750999 T ES21750999 T ES 21750999T ES 21750999 T ES21750999 T ES 21750999T ES 3025983 T3 ES3025983 T3 ES 3025983T3
- Authority
- ES
- Spain
- Prior art keywords
- mmol
- alkyl
- ethyl
- carbamate
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970425P | 2020-02-05 | 2020-02-05 | |
| PCT/US2021/016848 WO2021158936A1 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3025983T3 true ES3025983T3 (en) | 2025-06-10 |
Family
ID=77199407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES21750999T Active ES3025983T3 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4100008B1 (https=) |
| JP (1) | JP7678595B2 (https=) |
| CN (1) | CN115515579B (https=) |
| AU (1) | AU2021215925B2 (https=) |
| CA (1) | CA3170121A1 (https=) |
| ES (1) | ES3025983T3 (https=) |
| MX (1) | MX2022009572A (https=) |
| WO (1) | WO2021158936A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023015156A1 (en) * | 2021-08-02 | 2023-02-09 | Hudspeth A James | Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation |
| WO2024211621A1 (en) * | 2023-04-04 | 2024-10-10 | Children's Hospital Los Angeles | Lats kinase inhibitor to treat retinal degeneration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| WO2007067537A1 (en) * | 2005-12-07 | 2007-06-14 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine kinase inhibiting compounds |
| PE20121126A1 (es) * | 2006-12-21 | 2012-08-24 | Plexxikon Inc | Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa |
| TWI667233B (zh) * | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
| GB201602854D0 (en) * | 2016-02-18 | 2016-04-06 | Mission Therapeutics Ltd | Novel compounds |
| JOP20190257A1 (ar) | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
-
2021
- 2021-02-05 CA CA3170121A patent/CA3170121A1/en active Pending
- 2021-02-05 WO PCT/US2021/016848 patent/WO2021158936A1/en not_active Ceased
- 2021-02-05 AU AU2021215925A patent/AU2021215925B2/en active Active
- 2021-02-05 MX MX2022009572A patent/MX2022009572A/es unknown
- 2021-02-05 CN CN202180019399.6A patent/CN115515579B/zh active Active
- 2021-02-05 ES ES21750999T patent/ES3025983T3/es active Active
- 2021-02-05 JP JP2022548109A patent/JP7678595B2/ja active Active
- 2021-02-05 EP EP21750999.1A patent/EP4100008B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20230137893A1 (en) | 2023-05-04 |
| WO2021158936A1 (en) | 2021-08-12 |
| AU2021215925A1 (en) | 2022-09-08 |
| EP4100008B1 (en) | 2025-04-02 |
| JP7678595B2 (ja) | 2025-05-16 |
| MX2022009572A (es) | 2022-12-13 |
| CA3170121A1 (en) | 2021-08-12 |
| EP4100008A4 (en) | 2024-02-07 |
| JP2023512823A (ja) | 2023-03-29 |
| AU2021215925B2 (en) | 2026-04-09 |
| EP4100008A1 (en) | 2022-12-14 |
| CN115515579A (zh) | 2022-12-23 |
| CN115515579B (zh) | 2025-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2893289T3 (es) | Inhibidores de glucosidasa | |
| ES2770026T3 (es) | Derivados de imidazotiazol e imidazopirazina como inhibidores del receptor activado por proteasa 4 (PAR4) para tratar la agregación plaquetaria | |
| ES2287170T3 (es) | Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa. | |
| ES2761295T3 (es) | Métodos y composiciones para su uso en el tratamiento del cáncer y para reducir los efectos mediados por Wnt en una célula | |
| JP2019532995A (ja) | タウタンパク質標的化ｐｒｏｔａｃ、および関連使用方法 | |
| KR20230097015A (ko) | Mas-관련 G-단백질 수용체 X2의 조절제 및 관련 생성물 및 방법 | |
| ES2624421T3 (es) | Derivados de carbamato/urea que contienen anillos de piperidina y piperazina como inhibidores del receptor H3. | |
| TW202132307A (zh) | 雜環ｒｉｐ１抑制性化合物 | |
| BRPI0719861A2 (pt) | Compostos heteroaromáticos bicíclicos | |
| TW201710255A (zh) | 雜環化合物 | |
| AU2019218187B2 (en) | Dioxinoquinoline compounds, preparation method and uses thereof | |
| EP3137168A1 (en) | Substituted 4-phenylpiperidines, their preparaiton and use | |
| CA2993661A1 (en) | Benzazole compounds and methods for making and using the compounds | |
| JP2022521537A (ja) | イミダゾピリジニル化合物及び増殖性障害の処置のためのその使用 | |
| WO2014151630A2 (en) | Compounds and compositions for the treatment of parasitic diseases | |
| ES3025983T3 (en) | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss | |
| KR102636651B1 (ko) | 티아졸로피리딘 또는 이의 약학적으로 허용 가능한 염 및 이의 용도 | |
| WO2015114452A2 (en) | Antibacterial compounds | |
| ES2478042T3 (es) | Derivado de amida y composición farmacéutica que contiene el mismo | |
| WO2023185073A1 (zh) | Parp7抑制剂及其用途 | |
| CA3090876C (en) | Dioxinoquinoline compounds, preparation method and uses thereof | |
| US20240343726A1 (en) | Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation | |
| US12617785B2 (en) | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss | |
| WO2025180442A1 (zh) | Hdac抑制剂及其在医药上的应用 | |
| BR112023018850B1 (pt) | Compostos pde10, composição e usos destes |